Cargando…
Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multipl...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786409/ https://www.ncbi.nlm.nih.gov/pubmed/35114466 http://dx.doi.org/10.1016/j.bios.2022.114018 |
_version_ | 1784639109625544704 |
---|---|
author | Salahandish, Razieh Haghayegh, Fatemeh Ayala-Charca, Giancarlo Hyun, Jae Eun Khalghollah, Mahmood Zare, Azam Far, Behrouz Berenger, Byron M. Niu, Yan Dong Ghafar-Zadeh, Ebrahim Sanati-Nezhad, Amir |
author_facet | Salahandish, Razieh Haghayegh, Fatemeh Ayala-Charca, Giancarlo Hyun, Jae Eun Khalghollah, Mahmood Zare, Azam Far, Behrouz Berenger, Byron M. Niu, Yan Dong Ghafar-Zadeh, Ebrahim Sanati-Nezhad, Amir |
author_sort | Salahandish, Razieh |
collection | PubMed |
description | Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multiplexing to meet the requirements of point-of-care detection due to either limited functional biosensors for multi-electrode detection or incompatible readout systems. We developed a new dual electrochemical biosensing unit accompanied by a customized potentiostat to address the unmet need for point-of-care multi-electrode electrochemical biosensing. The two-working electrode system was developed using screen-printing of a carboxyl-rich nanomaterial containing ink, with both working electrodes offering active sites for recognition of bioanalytes. The low-cost bi-potentiostat system (∼$80) was developed and customized specifically to the bi-electrode design and used for rapid, repeatable, and accurate measurement of electrochemical impedance spectroscopy signals from the dual biosensor. This binary electrochemical data acquisition (Bi-ECDAQ) system accurately and selectively detected SARS-CoV-2 Nucleocapsid protein (N-protein) in both spiked samples and clinical nasopharyngeal swab samples of COVID-19 patients within 30 min. The two working electrodes offered the limit of detection of 116 fg/mL and 150 fg/mL, respectively, with the dynamic detection range of 1–10,000 pg/mL and the sensitivity range of 2744–2936 Ω mL/pg.mm(2) for the detection of N-protein. The potentiostat performed comparable or better than commercial Autolab potentiostats while it is significantly lower cost. The open-source Bi-ECDAQ presents a customizable and flexible approach towards addressing the need for rapid and accurate point-of-care electrochemical biosensors for the rapid detection of various diseases. |
format | Online Article Text |
id | pubmed-8786409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87864092022-01-25 Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins Salahandish, Razieh Haghayegh, Fatemeh Ayala-Charca, Giancarlo Hyun, Jae Eun Khalghollah, Mahmood Zare, Azam Far, Behrouz Berenger, Byron M. Niu, Yan Dong Ghafar-Zadeh, Ebrahim Sanati-Nezhad, Amir Biosens Bioelectron Article Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multiplexing to meet the requirements of point-of-care detection due to either limited functional biosensors for multi-electrode detection or incompatible readout systems. We developed a new dual electrochemical biosensing unit accompanied by a customized potentiostat to address the unmet need for point-of-care multi-electrode electrochemical biosensing. The two-working electrode system was developed using screen-printing of a carboxyl-rich nanomaterial containing ink, with both working electrodes offering active sites for recognition of bioanalytes. The low-cost bi-potentiostat system (∼$80) was developed and customized specifically to the bi-electrode design and used for rapid, repeatable, and accurate measurement of electrochemical impedance spectroscopy signals from the dual biosensor. This binary electrochemical data acquisition (Bi-ECDAQ) system accurately and selectively detected SARS-CoV-2 Nucleocapsid protein (N-protein) in both spiked samples and clinical nasopharyngeal swab samples of COVID-19 patients within 30 min. The two working electrodes offered the limit of detection of 116 fg/mL and 150 fg/mL, respectively, with the dynamic detection range of 1–10,000 pg/mL and the sensitivity range of 2744–2936 Ω mL/pg.mm(2) for the detection of N-protein. The potentiostat performed comparable or better than commercial Autolab potentiostats while it is significantly lower cost. The open-source Bi-ECDAQ presents a customizable and flexible approach towards addressing the need for rapid and accurate point-of-care electrochemical biosensors for the rapid detection of various diseases. Elsevier B.V. 2022-05-01 2022-01-25 /pmc/articles/PMC8786409/ /pubmed/35114466 http://dx.doi.org/10.1016/j.bios.2022.114018 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Salahandish, Razieh Haghayegh, Fatemeh Ayala-Charca, Giancarlo Hyun, Jae Eun Khalghollah, Mahmood Zare, Azam Far, Behrouz Berenger, Byron M. Niu, Yan Dong Ghafar-Zadeh, Ebrahim Sanati-Nezhad, Amir Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title | Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title_full | Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title_fullStr | Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title_full_unstemmed | Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title_short | Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins |
title_sort | bi-ecdaq: an electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of sars-cov-2 nucleocapsid proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786409/ https://www.ncbi.nlm.nih.gov/pubmed/35114466 http://dx.doi.org/10.1016/j.bios.2022.114018 |
work_keys_str_mv | AT salahandishrazieh biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT haghayeghfatemeh biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT ayalacharcagiancarlo biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT hyunjaeeun biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT khalghollahmahmood biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT zareazam biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT farbehrouz biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT berengerbyronm biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT niuyandong biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT ghafarzadehebrahim biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins AT sanatinezhadamir biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins |